low energy on glp-1 GLP-1s: how to move safely when appetite is low Glucagon, GLP-1 and Thermogenesis
Description
Recently, the GLP-1 RA semaglutide was reported to reduce cardiovascular events in ASCVD patients with overweight or obesity even in the absence of diabetes mellitus
We're not friends anymore
:max_bytes(150000):strip_icc()/Common-Symptoms-From-Taking-a-GLP-1-And-How-to-Manage-Them-9e5bb7cee0484522a50dd9d7ce954cc4.jpg)
Total Sugar
Gastric emptying AUC0300min was equivalent for liraglutide 1.8 and 3.0mg, and for liraglutide versus placebo, whereas reductions in 1-h gastric emptying of 23% with liraglutide 3.0mg and 13% with 1.8mg versus placebo were observed
The FDA is targeting telehealth marketing of GLP-1 drugs
